Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Cooper

Showing results (201-210 of 229) with videos related to

Pageof 23
Sort By:
Frontiers in Immunology|January 23, 2024
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapyAshley Priddey, Michael Xin Hua Chen-Xu, Daniel James Cooper, et al.
Science Advances|April 21, 2023
Cell-autonomous immune dysfunction driven by disrupted autophagy in <i>C9orf72</i>-ALS iPSC-derived microglia contributes to neurodegenerationPoulomi Banerjee, Arpan R Mehta, Raja S Nirujogi, et al.
Cell Reports|June 25, 2020
CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell SurvivalAdam Utley, Colin Chavel, Shivana Lightman, et al.
JAMA|February 14, 2008
Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trialMaureen O Meade, Deborah J Cook, Gordon H Guyatt, et al.
Journal of Neurotrauma|March 26, 2019
Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic AnalysisRachel J Knott, Anthony Harris, Alisa Higgins, et al.
Trials|April 29, 2018
Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled TrialJeffrey Presneill, Dashiell Gantner, Alistair Nichol, et al.
Critical Care (London, England)|June 22, 2013
Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrineSangeeta Mehta, John Granton, Anthony C Gordon, et al.
Critical Care (London, England)|May 5, 2017
Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrineSangeeta Mehta, John Granton, Anthony C Gordon, et al.
Orphanet Journal of Rare Diseases|June 25, 2024
Twice weekly dosing with Sebelipase alfa (Kanuma®) rescues severely ill infants with Wolman diseaseMaría José de Castro, Simon A Jones, Javier de Las Heras, et al.
JAMA|October 26, 2018
Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical TrialD James Cooper, Alistair D Nichol, Michael Bailey, et al.
Pageof 23

Showing results (201-210 of 229) with videos related to

Sort By:
Pageof 23
Frontiers in Immunology|January 23, 2024
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapyAshley Priddey, Michael Xin Hua Chen-Xu, Daniel James Cooper, et al.
Science Advances|April 21, 2023
Cell-autonomous immune dysfunction driven by disrupted autophagy in <i>C9orf72</i>-ALS iPSC-derived microglia contributes to neurodegenerationPoulomi Banerjee, Arpan R Mehta, Raja S Nirujogi, et al.
Cell Reports|June 25, 2020
CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell SurvivalAdam Utley, Colin Chavel, Shivana Lightman, et al.
JAMA|February 14, 2008
Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trialMaureen O Meade, Deborah J Cook, Gordon H Guyatt, et al.
Journal of Neurotrauma|March 26, 2019
Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic AnalysisRachel J Knott, Anthony Harris, Alisa Higgins, et al.
Trials|April 29, 2018
Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled TrialJeffrey Presneill, Dashiell Gantner, Alistair Nichol, et al.
Critical Care (London, England)|June 22, 2013
Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrineSangeeta Mehta, John Granton, Anthony C Gordon, et al.
Critical Care (London, England)|May 5, 2017
Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrineSangeeta Mehta, John Granton, Anthony C Gordon, et al.
Orphanet Journal of Rare Diseases|June 25, 2024
Twice weekly dosing with Sebelipase alfa (Kanuma®) rescues severely ill infants with Wolman diseaseMaría José de Castro, Simon A Jones, Javier de Las Heras, et al.
JAMA|October 26, 2018
Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical TrialD James Cooper, Alistair D Nichol, Michael Bailey, et al.
Pageof 23